查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血压计市场 - 2023-2030
市场调查报告书
商品编码
1345399

全球血压计市场 - 2023-2030

Global Sphygmomanometer Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球血压计市场规模达到28亿美元，预计到2030年将实现利润丰厚的增长，达到52亿美元。预计全球血压计市场在预测期内（2023-2030年）复合年增长率为8.3 % ）。家庭护理环境中越来越多地采用血压计是市场的主要趋势之一。

血压计由缠绕在手臂上的橡胶杯、橡胶杯固有的灯泡、释放压力的阀门以及测量橡胶杯压力的测量仪器组成。数字或电子血压计采用示波测量方法。它操作简单、电池供电、自动化且不含汞。

数字血压计包括手动、自动、腕式、上臂式、新生儿和儿童血压计。最常用的血压计是腕式血压计和自动数字血压计。

市场动态

血压计的技术进步

血压计对于评估血压以进行诊断和管理至关重要，审查的重点是其功能和技术进步。消费者医疗保健领域的技术进步，例如可穿戴技术、应用程序和手机的创新，以及零售商和製造商平均售价的降低，正在推动公司的增长。

Microlife WatchBP home A、QardioArm、LifeSource Sophisticated 一步式自动充气血压监测仪和 Omron Healthcare 的 iHealth 血压监测仪是市场上技术最先进的数字血压监测仪。 Omron Healthcare 是一家着名的数字血压监测仪製造商，包括 Omron Platinum 和 Evolv 无线上臂监测仪。

家庭护理环境中越来越多地采用血压计

在过去几年中，远程医疗的使用有所增加。儘管 COVID-19 大流行是导致人们从定期就诊转向虚拟就诊的原因，但患者很快意识到远程医疗还有其他优势。远程医疗可以提供医生以前寻求的精确、及时的医疗建议。随着远程医疗的日益普及，家庭监测血压等健康数据的需求变得至关重要。

家庭护理环境中的血压计通过允许患者在家中测试血压来提供便利、可及性并改善健康结果。这可以实现更频繁的监测、改善高血压控制、早期诊断和避免异常、及时治疗和个性化护理。家庭血压监测还可以减少就诊次数，避免出现问题和住院治疗，从而具有成本效益。

市场竞争加剧

阻碍血压计市场增长的主要因素之一是供应商之间的激烈竞争以及未经授权产品的存在。由于一些新的小公司以及成熟供应商的存在，该行业的竞争变得异常激烈。大多数血压计在形式和技术上都具有可比性，并且可以从国外和本地供应商处购买。跨国公司在营销、促销和品牌质量开发方面投入大量资金，以实现利润率最大化。

COVID-19 影响分析

COVID-19将对血压计行业产生巨大影响，因为由于病毒性疾病的间接传播，高血压患者更容易受到感染。医疗保健从业人员常用的血压计含有可能通过人体皮肤传播的病菌和细菌。因此，能够在不冒感染风险的情况下测试和监测自己的血压将增加市场收入。

俄乌战争影响分析

俄罗斯和乌克兰的衝突增加了慢性非传染性疾病的医疗负担，而此前慢性非传染性疾病所占比例最大。消极的应对技巧，如增加饮酒和吸烟，加剧了这些健康问题，可能增加心血管风险，尤其是高血压，并增加未来对血压计的需求。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 按产品分类的片段
  • 按操作的片段
  • 按配置分類的片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 血压计的技术进步
      • 家庭护理环境中越来越多地采用血压计
    • 限制
      • 市场竞争加剧
    • 机会
      • 新兴市场的增长机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情况
    • Covid-19 后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：副产品

  • 电子血压计
  • 无液血压计
  • 水银血压计

第 8 章：通过操作

  • 自动的
  • 半自动
  • 其他的

第 9 章：按配置

  • 便携的
  • 桌面安装式
  • 落地式
  • 壁挂式

第 10 章：最终用户

  • 医院
  • 诊断实验室
  • 家庭护理

第 11 章：按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • OMRON Corporation
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • 3B Scientiifc
  • Acoma Medical Industry Co
  • AmbulanceMed
  • American Diagnostic Corporation
  • Amico Group of Companies
  • AD Company Ltd
  • Bremed Ltd.
  • CIGA Healthcare Ltd
  • HEINE Optotechnik GmbHCo. KG

第 14 章：附录

简介目录
Product Code: MD6757

Overview

The global Sphygmomanometer market reached US$ 2.8 billion in 2022 and is estimated to witness lucrative growth by reaching up to US$ 5.2 billion by 2030. The global Sphygmomanometer market is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030). Increasing adoption of Sphygmomanometers in homecare settings is one of the key trend of the market.

A sphygmomanometer consists of a rubber cup wrapped around the arm, a bulb to innate the cup, a valve to release the pressure, and a measuring instrument to measure the cup's pressure. A digital or electronic sphygmomanometer employs an oscillometric measurement approach. It is simple to operate, battery-powered, automated, and mercury-free.

Digital sphygmomanometers include manual, automatic, wrist, upper arm, neonatal, and paediatric sphygmomanometers. The most often used sphygmomanometers are wrist and automated digital sphygmomanometers.

Market Dynamics

Technological Advancements in Sphygmomanometers

Sphygmomanometers are crucial for assessing blood pressure for diagnosis and management, with reviews focusing on their functionality and advancements in technology. Technological advancements in the consumer healthcare category, such as innovations in wearable technology, apps, and mobiles, as well as reducing average selling prices for retailers and manufacturers, are boosting firm growth.

Microlife WatchBP home A, QardioArm, LifeSource Sophisticated one-step auto inflate blood pressure monitor, and Omron Healthcare's iHealth blood pressure monitor are some of the most technologically sophisticated digital BP monitors on the market. Omron Healthcare is a well-known manufacturer of digital blood pressure monitors, including the Omron Platinum and Evolv Wireless Upper Arm Monitors.

Increasing Adoption of Sphygmomanometers In Homecare Settings

Over the previous few years, telehealth usage has increased. Patients quickly realized that there were additional advantages to telemedicine, despite the fact that the COVID-19 pandemic was the reason for the move from regular clinic visits to virtual ones. Telemedicine can deliver precise and prompt healthcare suggestions that were previously sought by a doctor. With this rising adoption of telehealth, the need for at-home monitoring of health data such as blood pressure has become crucial.

Sphygmomanometers in homecare settings provide convenience, accessibility, and improved health outcomes by allowing patients to test their blood pressure at home. This results in more frequent monitoring, improved hypertension control, early diagnosis and avoidance of anomalies, prompt treatments, and personalised care. Home blood pressure monitoring also decreases clinic visits and avoids problems and hospitalisations, making it cost-effective.

Increasing Competition in the Market

One of the primary factors hindering the growth of the sphygmomanometer market is strong competition among providers, as well as the presence of unauthorised products. The industry has grown extremely competitive as a result of the existence of several new and small firms, as well as well-established vendors. The majority of sphygmomanometers are comparable in form and technology, and they are available from both foreign and local vendors. Multinational firms invest much in marketing, promotion, and brand quality development to maximise their profit margins.

COVID-19 Impact Analysis

COVID-19 will had a numerous impact on the sphygmomanometer industry since people with high blood pressure will be more susceptible to infection owing to the indirect transmission of viral illnesses. Blood pressure monitors are commonly used by healthcare practitioners and contain germs and bacteria that may be transmitted through human skin. As a result, being able to test and monitor one's own blood pressure without risking infection will boost market revenue.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has increased the healthcare burden for chronic noncommunicable illnesses, which previously accounted for the largest portion. Negative coping techniques, like increased alcohol use and smoking, have exacerbated these health concerns, potentially increasing cardiovascular risks, especially hypertension, and increasing the need for sphygmomanometers in the future.

Segment Analysis

The global sphygmomanometer is segmented based on product, operation, configuration, end user and region.

HomeCare Settings From the End User Segment Accounts for 37.3% of Market Share Owing to Rising Novel Product Launches

The homecare settings from the end user segment with around 37.3% is expected to dominate during the forecast period owing to an increase in the usage of homecare digital sphygmomanometers with sophisticated technology that can communicate patient information wirelessly to clinicians.

For instance, in January 2022, OMRON Healthcare, Inc., a subsidiary of OMRON Corporation, launched Remote Patient Monitoring Services. The service would broaden Digital Health Services to support consumers on each step of their heart health journey. Moreover, this service is created to strengthen the guide behaviour change, patient-physician connection, and reducing risk.

Geographical Analysis

Asia Pacific estimated to hold for Approximately 38.4% of the Market Share

Asia Pacific is estimated to hold about 38.4% of the total market share in the forecasted period, due to the availability of untapped potential, growing hypertension prevalence, and rising awareness levels, is expected to rise substantially over the projected period.

Rapidly improving healthcare facilities, as well as a rise of misdiagnosed patients, are driving regional market expansion. Government efforts to improve public awareness, as well as a rapidly growing target disease population base, are all contributing to the lucrative expansion of this area's BP monitoring devices industry.

For instance, in March 2023, Xiaomi launched the MIJIA electronic blood pressure monitor in China, also known as the MIJIA Electronic Sphygmomanometer. This tie-free device measures blood pressure with just one clamp and stick, eliminating the need for repeated cuff adjustments.

Competitive Landscape

The major global players in the sphygmomanometer include: OMRON Corporation, 3B Scientific, Acoma Medical Industry Co, AmbulanceMed, American Diagnostic Corporation, Amico Group of Companies, A D Company Ltd, Bremed Ltd., CIGA Healthcare Ltd, HEINE Optotechnik GmbHCo. KG and among others.

Why Purchase the Report?

  • To visualize the global sphygmomanometer market segmentation based on product, operation, configuration, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of sphygmomanometer market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global sphygmomanometer report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Operation
  • 3.3. Snippet by Configuration
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements in Sphygmomanometers
      • 4.1.1.2. Increasing Adoption of Sphygmomanometers In Homecare Settings
    • 4.1.2. Restraints
      • 4.1.2.1. Increasing Competition in the Market
    • 4.1.3. Opportunity
      • 4.1.3.1. Growth Opportunities in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Electronic Sphygmomanometer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Aneroid Sphygmomanometer
  • 7.4. Mercury Sphygmomanometer

8. By Operation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 8.1.2. Market Attractiveness Index, By Operation
  • 8.2. Automatic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Semi automatic
  • 8.4. Others

9. By Configuration

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 9.1.2. Market Attractiveness Index, By Configuration
  • 9.2. Portable *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Desk Mounted
  • 9.4. Floor standing
  • 9.5. Wall Mounted

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Laboratories
  • 10.4. Homecare

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. OMRON Corporation*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. 3B Scientiifc
  • 13.3. Acoma Medical Industry Co
  • 13.4. AmbulanceMed
  • 13.5. American Diagnostic Corporation
  • 13.6. Amico Group of Companies
  • 13.7. A D Company Ltd
  • 13.8. Bremed Ltd.
  • 13.9. CIGA Healthcare Ltd
  • 13.10. HEINE Optotechnik GmbHCo. KG

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us